Page 19 - Read Online

18. Báez J, Olsen D, Polarek JW. Recombinant microbial systems for the response and in vivo degradation of selected polyhydroxyacids: polylactides
production of human collagen and gelatin. Appl Microbiol Biotechnol (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-
2005;69:245-52. hydroxyvalerate) (PHB/VA). J Biomed Mater Res 1993;27:1135-48.
19. Raines RT. Stronger and (now) Longer Synthetic Collagen. Adv Exp Med Biol 45. Vleggaar D, Bauer U. Facial enhancement and the European experience with
2009;611:xci-xcviii. Sculptra (poly-l-lactic acid). J Drugs Dermatol 2004;3:542-7.
20. Bauman L. CosmoDerm/CosmoPlast (human bioengineered collagen) for 46. Fitzgerald R, Vleggaar D. Facial volume restoration of the aging face with poly-
the aging face. Facial Plastic Surg 2004;20:125-8. l-lactic acid. Dermatol Ther 2011;24:2-27.
21. Sclafani AP, Romo T 3rd. Collagen, human collagen, and fat: the search for a 47. Burgess CM, Quiroga RM. Assessment of the safety and efficacy of poly-L-
three-dimensional soft tissue filler. Facial Plastic Surg 2001;17:79-85. lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad
22. Stolman LP. Human collagen reactions. Dermatol Surg 2005;31:1634. Dermatol 2005;52:233-9.
23. Sclafani AP, Romo T 3rd, Jacono AA. Rejuvenation of the aging lip with an 48. Schierle CF, Casas LA. Nonsurgical rejuvenation of the aging face with
injectable acellular dermal graft (Cymetra). Arch Facial Plast Surg 2002;4:252- injectable poly-L-lactic acid for restoration of soft tissue volume. Aesthet Surg
7. J 2011;31:95-109.
24. Lowe NJ, Maxwell CA, Lowe P, Duick MG, Shah K. Hyaluronic acid skin 49. Woerle B, Hanke CW, Sattler G. Poly-L-lactic acid: a temporary filler for soft
fillers: adverse reactions and skin testing. J Am Acad Dermatol 2001;45:930-3. tissue augmentation. J Drugs Dermatol 2004;3:385-9.
25. Narins RS, Brandt F, Leyden J, Lorenc ZP, Rubin M, Smith S. A randomized, 50. Valantin MA, Aubron-Olivier C, Ghosn J, Laglenne E, Pauchard M, Schoen H,
double-blind, multicenter comparison of the efficacy and tolerability of Bousquet R, Katz P, Costagliola D, Katlama C. Polylactic acid implants (New-
Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-
2003;29:588-95. label study VEGA. AIDS 2003;17:2471-7.
26. Lindqvist C, Tveten S, Bondevik BE, Fagrell D. A randomized, evaluator-blind, 51. Moyle GJ, Lysakova L, Brown S, Sibtain N, Healy J, Priest C, Mandalia S, Barton
multicenter comparison of the efficacy and tolerability of Perlane versus SE. A randomized open-label study of immediate versus delayed polylactic
Zyplast in the correction of nasolabial folds. Plast Reconstr Surg 2005;115:282- acid injections for the cosmetic management of facial lipoatrophy in persons
9. with HIV infection. HIV Med 2004;5:82-7.
27. Wang F, Garza LA, Kang S, Varani J, Orringer JS, Fisher GJ, Voorhees JJ. In vivo 52. Lowe NJ, Maxwell CA, Lowe P, Shah A, Patnaik R. Injectable poly-l-lactic acid:
stimulation of de novo collagen production caused by cross-linked hyaluronic 3 years of aesthetic experience. Dermatol Surg 2009;35:344-9.
acid dermal filler injections in photodamaged human skin. Arch Dermatol 53. Palm MD, Woodhall KE, Butterwick KJ, Goldman MP. Cosmetic use of poly-l-
2007;143:155-63. lactic acid: a retrospective study of 130 patients. Dermatol Surg 2010;36:161-
28. Monheit GD, Coleman KM. Hyaluronic acid fillers. Dermatol Ther 2006;19:141- 70.
50. 54. Rossner F, Rossner M, Hartmann V, Erdmann R, Wiest LG, Rzany B. Decrease
29. Beer K. A randomized, evaluator-blinded comparison of efficacy of hyaluronic of reported adverse events to injectable polylactic acid after recommending
acid gel and avian-sourced hylan B plus gel for correction of nasolabial folds. an increased dilution: 8-year results from the Injectable Filler Safety study. J
Dermatol Surg 2007;33:928-36. Cosmet Dermatol 2009;8:14-8.
30. Prager W, Wissmueller E, Havermann I, Bee EK, Howell DJ, Zschocke I, 55. Hobar PC, Pantaloni M, Byrd HS. Porous hydroxyapatite granules for
Simon J. A prospective, split-face, randomized, comparative study of safety alloplastic enhancement of the facial region. Clin Plast Surg 2000;27:557-69.
and 12-month longevity of three formulations of hyaluronic acid dermal filler 56. Pavicic T. Calcium hydroxylapatite filler: an overview of safety and tolerability.
for treatment of nasolabial folds. Dermatol Surg 2012;38:1143-50. J Drugs Dermatol 2013;12:996-1002.
31. Kim H, Park KY, Choi SY, Koh HJ, Park SY, Park WS, Bae IH, Kim BJ.The 57. Marmur ES, Phelps R, Goldberg DJ. Clinical, histologic and electron
efficacy, longevity, and safety of combined radiofrequency treatment and microscopic findings after injection of a calcium hydroxylapatite filler. J Cosmet
hyaluronic Acid filler for skin rejuvenation. Ann Dermatol 2014;26:447-56. Laser Ther 2004;6:223-6.
32. Choi SY, Lee YH, Kim H, Koh HJ, Park SY, Park WS, Bae IH, Park KY, Kim BJ. 58. Moers-Carpi M, Vogt S, Santos BM, Planas J, Vallve SR, Howell DJ. A multicenter,
A combination trial of intradermal radiofrequency and hyaluronic acid filler randomized trial comparing calcium hydroxylapatite to two hyaluronic acids
for the treatment of nasolabial fold wrinkles: a pilot study. J Cosmet Laser Ther for treatment of nasolabial folds. Dermatol Surg 2007;33:S144-51.
2014;16:37-42. 59. Jacovella PF. Use of calcium hydroxylapatite (Radiesse) for facial augmentation.
33. Kanchwala SK, Holloway L, Bucky LP. Reliable soft tissue augmentation. Ann. Clin Interv Aging 2008;3:161-74.
Plas. Surg. 2005;55:30-5. 60. Bass LS, Smith SL, Busso M, McClaren M. Calcium hydroxylapatite (Radiesse)
34. Lemperle G, Ott H, Charrier U, Hecker J, Lemperle M. PMMA microspheres for treatment of nasolabial folds: long-term safety and efficacy results. Aesthet
for intradermal implantation: Part I. Animal research. Ann Plast Surg Surg J 2010;30:235-8.
1991;26:57-63. 61. Smith S, Busso M, McClaren M, Bass LS. A randomized, bilateral, prospective
35. Vent J, Lemperle G. Prevention and treatment of complications after comparison of calcium hydroxylapatite microspheres versus human-based
polymethylmethacrylate-microspheres injections. Facial Plast Surg collagen for the correction of nasolabial folds. Dermatol Surg 2007;33:S112-
2014;30:628-34. 21; discussion S21.
36. Lemperle G, Knapp TR, Sadick NS, Lemperle SM. ArteFill permanent 62. Chou CC, Chen HH, Tsai YY, Li YL, Lin HJ. Choroid vascular occlusion and
injectable for soft tissue augmentation: I. Mechanism of action and injection ischemic optic neuropathy after facial calcium hydroxyapatite injection- a
techniques. Aesthetic Plastic Surg 2010;34:264-72. case report. BMC Surg 2015;15:21.
37. Lemperle G, Sadick NS, Knapp TR, Lemperle SM. ArteFill permanent 63. Aronsohn RB. Observations on the use of silicone in the face. Arch Otolaryngol
injectable for soft tissue augmentation: II. Indications and applications. 1965;82:191-4.
Aesthetic Plastic Surg 2010;34:273-86. 64. Narins RS, Beer K. Liquid injectable silicone: a review of its history,
38. Cohen SR, Berner CF, Busso M, Clopton P, Hamilton D, Romano JJ, et al. immunology, technical considerations, complications, and potential. Plast
Five-year safety and efficacy of a novel polymethylmethacrylate aesthetic Reconstr Surg 2006;118:77S-84S.
soft tissue filler for the correction of nasolabial folds. Dermatol Surg 65. Hevia O. Six-year experience using 1,000-centistoke silicone oil in 916
2007;33:S222-30. patients for soft-tissue augmentation in a private practice setting. Dermatol
39. Cohen SR, Holmes RE. Artecoll: a long-lasting injectable wrinkle filler Surg 2009;35:1646-52.
material: Report of a controlled, randomized, multicenter clinical trial of 251 66. Jones DH, Carruthers A, Orentreich D, Brody HJ, Lai MY, Azen S, Van
subjects. Plast Reconstr Surg 2004;114:964-76; discussion 977-9. Dyke GS. Highly purified 1000-cSt silicone oil for treatment of human
40. Lemperle G, Gauthier-Hazan N, Lemperle M. PMMA-Microspheres (Artecoll) immunodeficiency virus-associated facial lipoatrophy: an open pilot trial.
for long-lasting correction of wrinkles: refinements and statistical results. Dermatol Surg 2004;30:1279-86.
Aesthetic Plastic Surg 1998;22:356-65. 67. Requena C, Requena L, Alegre V, Serra C, Llombart B, Nagore E, Guillén
41. Carvalho Costa IM, Salaro CP, Costa MC. Polymethylmethacrylate facial C, Sanmartín O. Adverse reaction to silicone simulating orofacial
implant: a successful personal experience in Brazil for more than 9 years. granulomatosis. J Eur Acad Dermatol Venereol 2015;29:998-1001.
Dermatol Surg 2009;35:1221-7. 68. Narins RS, Baumann L, Brandt FS, Fagien S, Glazer S, Lowe NJ, Monheit GD,
42. Donofrio L, Weinkle S. The third dimension in facial rejuvenation: a review. J Rendon MI, Rohrich RJ, Werschler WP. A randomized study of the efficacy and
Cosmet Dermatol 2006;5:277-83. safety of injectable poly-L-lactic acid versus human-based collagen implant in
43. Bartus C, William Hanke C, Daro-Kaftan E. A decade of experience with the treatment of nasolabial fold wrinkles. J Am Acad Dermatol 2010;62:448-62.
injectable poly-L-lactic acid: a focus on safety. Dermatol Surg 2013;39:698-705. 69. Coleman KR, Carruthers J. Combination therapy with BOTOX and fillers:
44. Gogolewski S, Jovanovic M, Perren SM, Dillon JG, Hughes MK. Tissue the new rejuvnation paradigm. Dermatol Ther 2006;19:177-88.

82 Plast Aesthet Res || Vol 3 || Mar 23, 2016